TTC4 inhibitors refer to a chemical class that targets the TTC4 protein, a tetratricopeptide repeat (TPR)-containing protein involved in various cellular processes. TPR motifs are known to mediate protein-protein interactions, and TTC4 has been shown to play a role in regulating signaling pathways, protein folding, and cellular homeostasis. TTC4 is also linked to functions within the ubiquitin-proteasome system, suggesting its involvement in protein degradation. Inhibitors of TTC4 specifically interact with the protein's structural domains, altering its ability to engage with other cellular proteins. The selective inhibition of TTC4 can modulate cellular signaling cascades and may lead to an altered balance in protein complex formation and stability within the cell.
The design of TTC4 inhibitors involves targeting its highly conserved TPR domains, aiming to disrupt key interactions that are fundamental for the protein's biological activity. These inhibitors are structurally diverse, with some being small molecules that mimic natural binding partners of TTC4, while others may involve larger biomolecules that interact more broadly with TTC4's conformational space. Researchers often use computational modeling and structure-activity relationship (SAR) studies to refine these inhibitors, ensuring that they effectively bind TTC4 with high specificity. By modulating TTC4's activity, these inhibitors provide a tool to study the protein's role in cellular pathways such as signal transduction, protein folding, and cellular stress responses, enabling a deeper understanding of its molecular function. The continuing exploration of TTC4 inhibitors thus represents an important area of biochemical research focused on elucidating complex cellular mechanisms.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR pathway, influencing several proteins' activities. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Affects PI3K, thereby influencing downstream signaling proteins. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Acts on p38 MAPK, potentially altering related pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MEK inhibitor that affects MAPK/ERK signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK inhibitor, impacting the JNK signaling pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad spectrum kinase inhibitor. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Inhibits NF-kB activation. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $130.00 | 12 | |
Acts on IKK-2, influencing the NF-kB pathway. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $82.00 $323.00 $219.00 $85.00 | 35 | |
JAK2 inhibitor, affecting JAK-STAT signaling. |